Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Moderate and Serious CFS/ME
NCT01730495Phase 2Terminated
- Sponsor
- Haukeland University Hospital
- Start
- Oct 2012
- Primary completion
- Aug 2014
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), myalgic encephalomyelitis (ME), sponsored by Haukeland University Hospital. Started Oct 2012; status: terminated.
02
Drugs
etanercept
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on NCT01730495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01730495.